Liyan Li

886 total citations
62 papers, 645 citations indexed

About

Liyan Li is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Liyan Li has authored 62 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 18 papers in Hematology and 17 papers in Genetics. Recurrent topics in Liyan Li's work include Complement system in diseases (16 papers), Hemoglobinopathies and Related Disorders (11 papers) and Renal Diseases and Glomerulopathies (10 papers). Liyan Li is often cited by papers focused on Complement system in diseases (16 papers), Hemoglobinopathies and Related Disorders (11 papers) and Renal Diseases and Glomerulopathies (10 papers). Liyan Li collaborates with scholars based in China, United States and United Kingdom. Liyan Li's co-authors include Xiangmin Xu, Ren Cai, Yongming Chen, Lixin Liu, Rong Fu, Qiuhua Mo, Li‐Yan Xu, En‐Min Li, Hong Ouyang and Hong Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and ACS Nano.

In The Last Decade

Liyan Li

59 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liyan Li China 15 191 187 165 160 146 62 645
Akanksha Chhabra United States 9 69 0.4× 277 1.5× 67 0.4× 125 0.8× 351 2.4× 15 774
Scott R. Witting United States 14 137 0.7× 405 2.2× 34 0.2× 106 0.7× 42 0.3× 21 761
Eduard H. Panosyan United States 14 161 0.8× 418 2.2× 331 2.0× 70 0.4× 90 0.6× 31 1.0k
Nicola Goekbuget Germany 19 147 0.8× 332 1.8× 360 2.2× 464 2.9× 72 0.5× 68 1.3k
Yi-Hsiang Chen United States 11 289 1.5× 329 1.8× 47 0.3× 338 2.1× 81 0.6× 11 679
Philip Ancliff United Kingdom 13 83 0.4× 393 2.1× 175 1.1× 417 2.6× 199 1.4× 24 1.1k
José Paulo Martins Portugal 13 276 1.4× 165 0.9× 21 0.1× 28 0.2× 85 0.6× 17 608
Laibin Liu United States 14 77 0.4× 360 1.9× 56 0.3× 17 0.1× 174 1.2× 19 911
Ugo Consoli Italy 17 181 0.9× 367 2.0× 44 0.3× 257 1.6× 239 1.6× 36 863
A. Knopp Germany 12 106 0.6× 326 1.7× 53 0.3× 162 1.0× 31 0.2× 15 660

Countries citing papers authored by Liyan Li

Since Specialization
Citations

This map shows the geographic impact of Liyan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyan Li more than expected).

Fields of papers citing papers by Liyan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyan Li. The network helps show where Liyan Li may publish in the future.

Co-authorship network of co-authors of Liyan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Liyan Li. A scholar is included among the top collaborators of Liyan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyan Li. Liyan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Liyan, L. Zhong, Haolin Chen, et al.. (2024). Montmorillonite nanosheets as an adjuvant eliciting potent cellular immunity. Chemical Engineering Journal. 481. 148612–148612. 9 indexed citations
3.
Yang, Zhaoxin, Zhirang Zhang, Liyan Li, et al.. (2024). Bioengineered Artificial Extracellular Vesicles Presenting PD-L1 and Gal-9 Ameliorate New-Onset Type 1 Diabetes. Diabetes. 73(8). 1325–1335. 20 indexed citations
4.
Liu, Hui, Zhaoyun Liu, Liyan Li, et al.. (2023). Defected lipid rafts suppress cavin1-dependent IFN-α signaling endosome in paroxysmal nocturnal hemoglobinuria. International Immunopharmacology. 115. 109468–109468. 5 indexed citations
5.
Wang, Honglei, Hui Liu, Liyan Li, et al.. (2023). Long noncoding RNA FAM157C contributes to clonal proliferation in paroxysmal nocturnal hemoglobinuria. Annals of Hematology. 102(2). 299–309. 2 indexed citations
6.
Li, Xiang, Liyan Li, Xiaodong Wu, et al.. (2022). Anti‐tumour effects of a macrolide analog F806 in oesophageal squamous cell carcinoma cells by targeting and promoting GLUT1 autolysosomal degradation. FEBS Journal. 289(21). 6782–6798. 3 indexed citations
7.
Fang, Wenli, Liyan Li, Yuan Li, et al.. (2022). Engineered IL-15/IL-15R α -expressing cellular vesicles promote T cell anti-tumor immunity. SHILAP Revista de lepidopterología. 2. 100021–100021. 15 indexed citations
8.
Chen, Haolin, et al.. (2022). Carrier-free subunit nanovaccine amplifies immune responses against tumors and viral infections. Acta Biomaterialia. 158. 525–534. 6 indexed citations
9.
Chen, Juanjuan, Qiang Li, Fenxia Li, et al.. (2021). The spectrum of FVIII gene variants detected by next generation sequencing in 236 Chinese non-inversion hemophilia A pedigrees. Thrombosis Research. 202. 8–13. 8 indexed citations
10.
Li, Liyan, et al.. (2020). MicroRNA‑329‑3p alleviates high glucose‑induced endothelial cell injury via inhibition of the TLR4/TRAF6/NF‑κB signaling pathway. Experimental and Therapeutic Medicine. 21(1). 1–1. 8 indexed citations
11.
Yang, Yanping, et al.. (2020). Prenatal detection of chromosomal abnormalities and copy number variants in fetuses with ventriculomegaly. European Journal of Paediatric Neurology. 25. 106–112. 12 indexed citations
12.
Ding, Kai, Hong‐Jeng Yu, Liyan Li, et al.. (2020). <p>Real-world Data on the Efficacy and Safety of Ixazomib-based Therapy in Multiple Myeloma: A Single-center Study in China</p>. Cancer Management and Research. Volume 12. 8935–8941. 6 indexed citations
13.
Li, Liyan, Jianzhong He, Xiu‐E Xu, et al.. (2019). Heat shock protein family B member 1 facilitates ezrin activation to control cell migration in esophageal squamous cell carcinoma. The International Journal of Biochemistry & Cell Biology. 112. 79–87. 7 indexed citations
14.
Zeng, Fa‐Min, Yang‐Min Xie, Lian‐Di Liao, et al.. (2016). Biological characterization of three immortalized esophageal epithelial cell lines. Molecular Medicine Reports. 14(5). 4802–4810. 5 indexed citations
15.
Yang, Kun, Yongjian Wu, Miao Li, et al.. (2016). Macrophage-mediated inflammatory response decreases mycobacterial survival in mouse MSCs by augmenting NO production. Scientific Reports. 6(1). 27326–27326. 37 indexed citations
16.
Chen, Wanqun, Xinhua Zhang, Xuan Shang, et al.. (2010). The molecular basis of beta-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity. BMC Medical Genetics. 11(1). 31–31. 54 indexed citations
17.
Li, Qiang, Liyan Li, Sheng‐Wen Huang, et al.. (2008). Rapid genotyping of known mutations and polymorphisms in β-globin gene based on the DHPLC profile patterns of homoduplexes and heteroduplexes. Clinical Biochemistry. 41(9). 681–687. 23 indexed citations
18.
Liu, Jia, Xuyang Wang, Liyan Li, et al.. (2008). Temporal changes in the expression of TGF-beta 1 and EGF in the ventral horn of the spinal cord and associated precentral gyrus in adult Rhesus monkeys subjected to cord hemisection. Journal of the Neurological Sciences. 268(1-2). 163–171. 10 indexed citations
19.
Liao, Can, Qiuhua Mo, Liyan Li, et al.. (2005). Carrier screening for ?- and ?-thalassemia in pregnancy: the results of an 11-year prospective program in Guangzhou Maternal and Neonatal hospital. Prenatal Diagnosis. 25(2). 163–171. 54 indexed citations
20.
Mo, Qiuhua, Hai Zhu, Liyan Li, & Xiangmin Xu. (2004). Reliable and High-Throughput Mutation Screening for β-Thalassemia by a Single-Base Extension/Fluorescence Polarization Assay. Genetic Testing. 8(3). 257–262. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026